HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday 16 April 2015

Cost-utility analysis in Asia

From the CEA Registry Blog

“In our recently published paper in Value in Health Regional Issues, “The State of Cost-Utility Analyses in Asia: A Systematic Review,” my colleagues and I review and evaluate published, English-language, cost-utility analyses (CUAs) targeting populations in Asia.

We analyzed data from the Tufts Medical Center Cost-Effectiveness Analysis Registry to summarize study features from these CUAs, such as country of study, disease area researched, study funder, and type of intervention. We also compared the Asian CUAs to CUAs focusing on non-Asian population across study features, methodological characteristics, and reporting practices, such as study perspective, discounting of costs and health benefits, time horizon, funding source, acceptability curves, and sensitivity analyses.”

The results?  Go here.